Global percutaneous coronary intervention (PCI) devices market size valuation to surpass USD 11 Bn mark by 2027

Description: The business intelligence document on ‘Percutaneous Coronary Intervention (PCI) Devices Market’ provides thorough insights pertaining to this industry vertical, including revenue growth pattern and total valuation over 2020-2027. It highlights the catalysts and prospects responsible for lucrative expansion of the market, alongside the challenges and restraints prevailing in the industry sphere.

As per the credible estimates, worldwide percutaneous coronary intervention (PCI) devices market is predicted to record robust growth, thereby amassing USD 11.4 billion by the year 2027. Increasing pervasiveness of coronary artery disorders (CAD), caused by sedentary lifestyle, smoking & alcohol consumption, or hereditary indicators, in consort with higher associated mortality rate are augmenting the market growth.

Percutaneous coronary intervention devices business is analyzed with respect to product terrain, and end-use scope, while emphasizing on the regional landscape. Industry share held by each segment along with their growth rate over the analysis timeframe are entailed in the report. It further aims to provide comprehensive understanding of the competitive dashboard of this industry vertical by presenting the company profiles and product portfolio of various vendors, and sheds light on different strategies incorporated by them to maintain stronghold in the market.

Request Sample copy of this Report @

Moreover, emphasis on improving the clinical results has led to a plethora of advancements including new stent technologies, innovative coronary catheters like PTA (percutaneous transluminal angioplasty balloon catheters and PTCA (percutaneous transluminal coronary angioplasty, and introduction of steel and nitinol based guide wire, which is turn is propelling the growth of worldwide percutaneous coronary intervention (PCI) devices industry size.

Though widespread preference for minimally invasive procedures will create a positive outlook, however surging instances of product recall may act as restraining factor for the overall market.

Product spectrum:

According to the report, global percutaneous coronary intervention devices industry share is divided into accessories, coronary stents, coronary guidewires, and coronary catheters.

End-use terrain:

Industry experts claims that percutaneous coronary intervention (PCI) devices market revenue from catheterization labs is slated to surge over the forthcoming years. The growth is creditable to increasing establishment of modern catheterization labs in developed nations. These labs offer services and undertake procedures like mitral valve repair, aortic valve replacement, PTCA, PCI, epicardial ablations of ventricular tachycardia, cardiac defibrillator implantation, pacemaker implantation, and intervention cardiac electrophysiological operations.  

Soaring number of PCI procedures, alongside set-up of catheterization labs by private hospitals and government facilities to provide enhanced services, as well as improving relationships between patient and surgeons are imparting impetus for the industry expansion.

To access a sample pages of this report titled “Percutaneous Coronary Intervention (PCI) Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Coronary Catheters, Coronary Guidewires, Coronary Stents, and Accessories); By End Use (Hospitals, Ambulatory Surgical Centers, and Catherization Labs); By Regions; Segment Forecast, 2020 -2027” in detail along with the table of contents, please click the link below:

Competitive landscape:

Well-established vendors in global percutaneous coronary intervention (PCI) devices market sphere are Meril Life Sciences Pvt. Ltd., Medtronic plc, Comed B.V., C. R. Bard Inc., Boston Scientific Corp., BIOTRONIK, Biosensors International Group Ltd., B. Braun, Asahi Intecc Co. Ltd., and Abbott Laboratories.

Percutaneous Coronary Intervention (PCI) Devices Market Product Terrain (Revenue, USD Million, 2016-2027)

  • Accessories
  • Coronary Stents
  • Coronary Guidewires
  • Coronary Catheters

Percutaneous Coronary Intervention (PCI) Devices Market End-use Scope (Revenue, USD Million, 2016-2027)

  • Catheterization Labs
  • Ambulatory Surgical Centers
  • Hospitals

Percutaneous Coronary Intervention (PCI) Devices Market Regional Gamut (Revenue, USD Million, 2016-2027)


  • Austria
  • Netherlands
  • Spain
  • Italy
  • United Kingdom
  • Germany
  • France

Central & South America

  • Argentina
  • Brazil
  • Mexico

Asia Pacific

  • South Korea
  • Indonesia
  • Malaysia
  • Japan
  • China
  • India

North America

  • Canada
  • United States

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • Israel
  • UAE

Percutaneous Coronary Intervention (PCI) Devices Market Competitive Hierarchy (Revenue, USD Million, 2016-2027)

  • Meril Life Sciences Pvt. Ltd.
  • Medtronic plc
  • Comed B.V.
  • C. R. Bard Inc.
  • Boston Scientific Corp.
  • Biosensors International Group Ltd.
  • B. Braun
  • Asahi Intecc Co. Ltd.
  • Abbott Laboratories.

Related Report:

Interventional Cardiology & Peripheral Vascular Devices Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

The interventional cardiology and peripheral vascular devices market is anticipated to witness tremendous gains in the coming years due to rising geriatric population, increasing innovations and adoption of stents across emerging economies, surging need for treatment of blood clots to prevent life-threatening health conditions, and growing number of cath labs as well as cardiac centers. Interventional cardiology is basically a specialty area within the larger field of cardiology. It deals mostly with catheter- based treatment of heart diseases. With rising geriatric population, the burden of PAD (peripheral artery disease) is increasing. The treatment for this is usually performed by interventional cardiologists, interventional radiologists, and vascular surgeons.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150


Back to news